AGBL offers Hematological Cancer solutions through Invivoscribe.
Dedicated to improving the standard of healthcare, Invivoscribe is a US based company which provides high quality, reliable, innovative molecular diagnostic tools and advanced healthcare information technology solutions.
Invivoscribe’s CE-marked IVD products are standardized solutions to identify, classify and monitor leukemias, lymphomas and other lymphoproliferative diseases.
Invivoscribe’s kits have been developed in partnership with EuroClonality/BIOMED-2 Group and are intended to target
specific clonal gene rearrangements, chromosome translocations and gene mutations. Each target can be tested
using the following technologies:
• Next-Generation Sequencing
• Capillary Electrophoresis
• Polyacrylamide Gel Electrophoresis
LymphoTrack Assays Invivoscribe
Assay kits are designed for the identification of gene rearrangements in hematologic samples utilizing
Next-Generation Sequencing (NGS) technologies. Taking advantage of the wealth and depth of NGS data platforms both the distribution of gene rearrangements and their DNA sequences can now be obtained. It is also possible to track
a specific rearrangement in subsequent samples!
LymphoTrack assay kits are available as CE-IVD and RUO options to fulfill all customer needs.
All kits contain the master mixes with indexed primers for amplification as well as the necessary controls.
The LymphoTrack assays are designed to be used in combination with the included bioinformatics software for easy analysis and visualization of the NGS data output.